COVID–19 Access to Testing and Support for Immune Response Research Act of 2021
Summary
COVID-19 Access to Testing and Support for Immune Response Research Act of 2021 This bill requires the Centers for Medicare & Medicaid Services to provide for coverage during the COVID-19 public health emergency of T-cell diagnostic laboratory tests for individuals with a current or prior COVID-19 infection. In addition, the Department of Health and Human Services must develop a national strategy to research the immune response to COVID-19 and may award research grants.
Bill status
in committee
1 of 4 stages cleared
Introduction
Oct 2021
Committee Review
Floor Vote
President
Introduced Oct 27, 2021
Last action Oct 28, 2021
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
4
Key actions
0
Committee
3
Oct 28, 2021
Committee
Referred to the Subcommittee on Health.
lower
Oct 27, 2021
Committee
Referred to the Subcommittee on Health.
lower
Oct 27, 2021
Committee
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
lower
Oct 27, 2021
Introduced
Introduced in House
lower
1 primary · 2 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Neal P. Dunn
RRepublican
Co
Gus M. Bilirakis
RRepublican
Co
Ronny Jackson
RRepublican
Ask Maddy
·
AI policy assistant
Ask Maddy about HR 5745
Scope: US
Hi! I can help you understand HR 5745. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline